Literature DB >> 22490429

Survival of patients after ST-elevation myocardial infarction: external validation of a predictive biomarker model.

Marthe A Kampinga, Peter Damman, Iwan C C van der Horst, Pier Woudstra, Wichert J Kuijt, Maarten W N Nijsten, Felix Zijlstra, Jan G P Tijssen, Robbert J de Winter, Bart J G L de Smet.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2012        PMID： 22490429     DOI： 10.1373/clinchem.2011.177675

Source DB:  PubMed          Journal:  Clin Chem        ISSN： 0009-9147            Impact factor:   8.327


× No keyword cloud information.
  2 in total

1.  Multiple biomarkers for the prediction of short and long-term mortality after ST-segment elevation myocardial infarction: the Amsterdam Groningen collaboration.

Authors:  Peter Damman; Marthe A Kampinga; Iwan C C van der Horst; Pier Woudstra; Maik J Grundeken; Wichert J Kuijt; Ralf E Harskamp; Maarten W N Nijsten; Felix Zijlstra; Jan G P Tijssen; Bart J G L de Smet; Robbert J de Winter
Journal:  J Thromb Thrombolysis       Date:  2013-07       Impact factor: 2.300

2.  Admission lipoprotein-associated phospholipase A2 activity is not associated with long-term clinical outcomes after ST-segment elevation myocardial infarction.

Authors:  Pier Woudstra; Peter Damman; Wichert J Kuijt; Wouter J Kikkert; Maik J Grundeken; Peter M van Brussel; An K Stroobants; Jan P van Straalen; Johan C Fischer; Karel T Koch; José P S Henriques; Jan J Piek; Jan G P Tijssen; Robbert J de Winter
Journal:  PLoS One       Date:  2014-05-01       Impact factor: 3.240
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.